Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Endocrine diseases in children can cause various skin and hair changes.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Precocious puberty is starting earlier due to factors like obesity and chemicals, with treatment focusing on preserving height and addressing social issues.

Early sexual development in children, especially girls, can be treated with hormone therapy to improve adult height and requires support for the child and family.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Higher early lead exposure is linked to delayed puberty in girls.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

A rare ovarian tumor caused early puberty in a 3-year-old girl.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Exercise-induced particles can slow breast cancer growth by boosting immune response.

Kenikir leaf extract nanosuspension may help inhibit breast cancer cell growth.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Different types of long-lasting stem cells are responsible for the growth and upkeep of the mammary gland.

The document concludes that rib-sparing techniques in breast reconstruction have limited benefits, sentinel lymph node biopsy is needed for desmoplastic melanoma, certain hair preservation methods improve graft survival, partial turbinectomy effectively reduces nasal obstruction, nipple shields with irrigation may reduce capsular contracture, and thicker malignant melanomas have a higher risk of non-skin cancers.

The document concludes that rib-sparing techniques in breast reconstruction have limited benefits, sentinel lymph node biopsy is needed for desmoplastic melanoma, certain hair preservation methods improve graft survival, partial turbinectomy effectively reduces nasal obstruction, nipple shields with irrigation may reduce capsular contracture, and thicker malignant melanomas have a higher risk of non-skin cancers.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.